Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Market Cap	989.25B
Revenue (ttm)	517.71B
Net Income (ttm)	64.68B
Shares Out	9.33M
EPS (ttm)	6,930.41
PE Ratio	15.29
Forward PE	n/a
Dividend	2,400.00 (2.30%)
Ex-Dividend Date	Sep 9, 2025

Volume	3,353,366
Average Volume	190,229
Open	105,900
Previous Close	104,200
Day's Range	104,500 - 106,000
52-Week Range	84,000 - 135,800
Beta	-0.33
RSI	47.62
Earnings Date	Oct 14, 2025

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. The company offers non-prescription drug products for gastrointestinal and hepatobiliary; cardiovascular; respiratory; central nervous; skeletal; hormones; anti-infectives; urinary; endocrine and metabolic; vitamins and minerals; eye; ear – mouth/ throat; dermatologicals; allergy and immune; cardiovascular; diabetes; and other systems. It also pro...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 535
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: PMC

Financial Performance

In 2024, HNX:PMC's revenue was 498.18 billion, an increase of 2.68% compared to the previous year's 485.19 billion. Earnings were 58.50 billion, a decrease of -4.11%.